Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Association between the genetic risk score and extramacular drusen in an age-related macular degeneration cohort - The Coimbra Eye Study
Author Affiliations & Notes
  • Rita Coimbra
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Mathematics, Universidade de Aveiro, Aveiro, Aveiro, Portugal
  • Claudia Farinha
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Coimbra, Portugal
  • Patrícia Barreto
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Universidade de Coimbra Instituto de Investigacao Clinica e Biomedica de Coimbra, Coimbra, Coimbra, Portugal
  • Maria da Luz Cachulo
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Coimbra, Portugal
  • José Cunha-Vaz
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
  • Yara Lechanteur
    Radboud Universiteit Donders Institute for Brain Cognition and Behaviour, Nijmegen, Gelderland, Netherlands
  • Carel C B Hoyng
    Radboud Universiteit Donders Institute for Brain Cognition and Behaviour, Nijmegen, Gelderland, Netherlands
  • Rufino Silva
    Associacao para a Investigacao Biomedica e Inovacao em Luz e Imagem, Coimbra, Coimbra, Portugal
    Ophthalmology, Centro Hospitalar e Universitario de Coimbra EPE, Coimbra, Coimbra, Portugal
  • Footnotes
    Commercial Relationships   Rita Coimbra None; Claudia Farinha Novartis, Code C (Consultant/Contractor), Bayer, Code C (Consultant/Contractor); Patrícia Barreto None; Maria da Luz Cachulo None; José Cunha-Vaz Bayer, Code C (Consultant/Contractor), Ciana Therapeutics, Code C (Consultant/Contractor), Adverum Biotechnologies, Code C (Consultant/Contractor), NovaGo Therapeutics, Code C (Consultant/Contractor), Roche, Code C (Consultant/Contractor), Emerton, Code C (Consultant/Contractor), Carl Zeiss Meditec, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor); Yara Lechanteur Novartis, Code R (Recipient), Bayer, Code R (Recipient), Oogvitaal, Code R (Recipient); Carel Hoyng None; Rufino Silva Allimera Sciences, Code C (Consultant/Contractor), Novartis, Code C (Consultant/Contractor), Alcon, Code C (Consultant/Contractor), Allergan, Code C (Consultant/Contractor), Bayer, Code C (Consultant/Contractor), Thea, Code C (Consultant/Contractor)
  • Footnotes
    Support  Novartis
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4389. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rita Coimbra, Claudia Farinha, Patrícia Barreto, Maria da Luz Cachulo, José Cunha-Vaz, Yara Lechanteur, Carel C B Hoyng, Rufino Silva; Association between the genetic risk score and extramacular drusen in an age-related macular degeneration cohort - The Coimbra Eye Study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4389.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the association between the genetic risk score (GRS) for AMD and the presence of extramacular drusen (EMD) and to explore if EMD share a common genetic basis with AMD.

Methods : For EMD classification, the 3-field 45-degree color fundus photography images were re-evaluated for drusen presence outside the macular grid, and characteristics including size, type, location, and predominance in distribution compared to the macula, were analyzed. GRS for AMD was calculated with 52 single nucleotide polymorphisms identified by the International AMD Genomics Consortium. GRS was compared between groups: 1) AMD without EMD, 2) AMD with EMD, 3) EMD without AMD, and 4) healthy controls. Associations of GRS with EMD and AMD were assessed using generalized estimated equations logistic regression models, adjusting for age and sex.

Results : 1.846 eyes (939 subjects) were included in EMD grading: 902 eyes had no macular drusen or EMD, 570 eyes had EMD without AMD, 252 eyes had EMD and AMD, and 122 eyes had AMD without EMD. Small hard drusen and intermediate soft drusen were the most common EMD, but the percentage of extramacular large soft drusen was higher in those with co-existing AMD compared to those without(60.7% vs 24.0%). For the genetic association analysis, the phenotype-genotype sample comprised 1.612 eyes(829 subjects) – 346 eyes with AMD and 1266 eyes without AMD. The GRS for control eyes was inferior compared to AMD eyes with and without EMD (p=1.4e-07;p=0.0001), and the GRS for eyes with only EMD was also inferior compared with AMD eyes with and without EMD (p= 2.5e-05,p=0.0019). The overlap in GRS distribution between the 4 groups was substantial. There was a strong association between EMD and AMD, with eyes with EMD showing an approximately 3-fold increased risk for AMD compared to eyes without EMD (OR=3.118,95% CI 2.239-4.342,p<0.001). The GRS was associated with AMD (OR=1.444,95% CI 1.248-1.670,p<0.001) but no association with EMD was found, adjusting for coexistence of AMD (OR=1.092,95% CI 0.964-1.235,p=0.16).

Conclusions : There is a relationship between the presence of macular drusen in AMD and EMD, and the presence of one increases the risk of the other, suggesting common pathogenesis. GRS was tailored for genetic AMD risk and a future analysis to assess single variants should be considered.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×